Centene Strengthens Board with Paul J. Diaz Appointment Following Kenneth A. Burdick’s Retirement
Centene Corporation, one of the largest healthcare enterprises in the United States, has announced significant changes to its Board of Directors as the company continues to strengthen its governance and position itself for long-term growth. Effective July 28, 2026, Kenneth A. Burdick has officially retired from Centene’s Board of Directors, concluding several years of service that helped guide the organization through an evolving healthcare landscape. At the same time, the company has appointed Paul J. Diaz to its Board, bringing an accomplished healthcare executive with decades of leadership experience across healthcare services, precision medicine, private equity, and corporate governance.
The leadership transition reflects Centene’s ongoing commitment to maintaining a highly experienced Board capable of supporting the company’s strategic priorities while navigating the rapidly changing healthcare environment. As healthcare organizations face increasing demands related to affordability, technology adoption, regulatory compliance, and patient-centered care, board leadership plays a crucial role in shaping long-term business direction and ensuring sustainable growth.
Leadership Transition Marks a New Chapter
The retirement of Kenneth A. Burdick represents the conclusion of an important chapter in Centene’s governance. Since joining the company’s Board of Directors in January 2022, Burdick has contributed valuable strategic guidance rooted in decades of executive leadership within the healthcare industry.
His appointment to the Board followed an already distinguished career with Centene itself. Before becoming a director, Burdick served as Executive Vice President of Products and Markets, where he helped oversee strategic initiatives designed to improve healthcare delivery and strengthen the company’s market position. Prior to his tenure at Centene, Burdick served as Chief Executive Officer of WellCare Health Plans, one of the nation’s leading managed care organizations before its acquisition by Centene.
Throughout his career, Burdick developed a reputation for driving operational excellence, improving health plan performance, and expanding access to quality healthcare services for diverse populations. His extensive understanding of government-sponsored healthcare programs, Medicare Advantage, Medicaid managed care, and commercial insurance markets made him a valuable advisor during his time on Centene’s Board.
His contributions helped support Centene during a period marked by industry transformation, evolving reimbursement models, digital health expansion, and increasing emphasis on value-based care.
A Career Dedicated to Healthcare Leadership
Kenneth Burdick’s healthcare career spans several decades and includes leadership roles across some of the industry’s most recognized organizations. His experience encompasses health plan management, operational transformation, strategic growth initiatives, and product development.
During his leadership at WellCare Health Plans, Burdick guided the organization through significant expansion while maintaining a focus on improving healthcare access for Medicare and Medicaid beneficiaries. His subsequent executive role at Centene enabled him to contribute directly to product innovation and market strategy before transitioning into a governance role as a Board member.
As a director, Burdick brought practical operational experience that complemented the broader governance responsibilities of the Board. His understanding of payer operations, regulatory frameworks, provider relationships, and healthcare policy provided valuable insight during discussions surrounding corporate strategy and organizational priorities.
Retirement Focused on Personal Priorities
In announcing his retirement, Burdick explained that the decision followed careful consideration and reflects his desire to devote more time to personal priorities while exploring new opportunities outside the Boardroom.
Although stepping away from formal governance responsibilities, Burdick expressed confidence in Centene’s future and praised the organization’s leadership team, strategic direction, and mission-driven culture.
He emphasized that serving on the Board had been a privilege and highlighted the company’s ongoing commitment to transforming the health of communities across the country. According to Burdick, Centene is well-positioned to continue expanding its impact while delivering value for members, providers, communities, and shareholders.
His remarks reflected both appreciation for the opportunity to serve and optimism regarding Centene’s future trajectory.
Board Expresses Appreciation
Frederick H. Eppinger, Chair of Centene’s Board of Directors, acknowledged Burdick’s meaningful contributions during his tenure.
According to Eppinger, Burdick’s extensive healthcare expertise, thoughtful strategic perspective, and unwavering commitment to improving healthcare delivery significantly strengthened Board discussions and corporate decision-making.
The Board recognized not only Burdick’s professional accomplishments but also his collaborative leadership style and dedication to Centene’s mission of improving health outcomes for underserved populations.
The organization expressed gratitude for his years of service and wished him continued success and fulfillment in retirement.
Welcoming Paul J. Diaz
As Burdick concludes his Board service, Centene has appointed Paul J. Diaz as its newest director, effective immediately.
Diaz brings an exceptional combination of executive leadership, investment experience, operational expertise, and public company governance that aligns closely with Centene’s long-term strategic priorities.
Currently serving as Managing Partner at Cressey & Company, Diaz helps lead investments in high-quality healthcare organizations across multiple sectors of the healthcare industry. The private investment firm is recognized for partnering with healthcare businesses that demonstrate strong growth potential while improving care delivery, operational performance, and patient outcomes.
His investment perspective adds another dimension to Centene’s Board by combining operational healthcare experience with financial strategy and organizational transformation.
Extensive Executive Experience
Before joining Cressey & Company, Diaz served as President and Chief Executive Officer of Myriad Genetics, Inc., one of the world’s leading companies specializing in genetic testing and precision medicine.
During his leadership, Myriad Genetics expanded its focus on personalized medicine by developing innovative diagnostic solutions that enable physicians to make more informed treatment decisions based on individual genetic information.
His experience in precision medicine provides Centene with valuable insight as personalized healthcare becomes increasingly integrated into mainstream clinical practice.
Genomic technologies continue to reshape disease prevention, early diagnosis, cancer treatment, and chronic disease management. Having leadership expertise in this rapidly growing field positions Diaz to contribute meaningfully as healthcare continues evolving toward individualized patient care.
Leading a Fortune 500 Healthcare Organization
Prior to Myriad Genetics, Diaz served as President and Chief Executive Officer of Kindred Healthcare, a Fortune 500 healthcare services company.
Kindred Healthcare operated one of the nation’s largest post-acute care networks, providing rehabilitation, long-term acute care, home health, hospice, and skilled nursing services.
Managing such a large and diversified healthcare enterprise required balancing clinical quality, operational efficiency, workforce management, regulatory compliance, and financial performance.
Diaz successfully guided the organization through periods of industry change while maintaining a strong focus on patient care and organizational performance.
This operational background provides Centene with Board-level expertise across healthcare delivery systems that complement the company’s managed care operations.
Strong Governance Experience
In addition to executive leadership, Diaz has accumulated significant experience serving on the boards of publicly traded healthcare companies.
His previous Board service includes organizations such as DaVita and PharMerica, where he participated in governance, strategic oversight, risk management, executive compensation, compliance, and long-term planning.
Board experience is increasingly valuable as healthcare companies navigate evolving regulatory requirements, cybersecurity risks, digital transformation initiatives, and changing reimbursement structures.
Diaz’s governance expertise strengthens Centene’s oversight capabilities while adding diverse perspectives that support effective corporate decision-making.
Supporting Centene’s Strategic Direction
Centene continues executing a long-term strategy centered on improving healthcare accessibility, affordability, quality, and outcomes for millions of members across government-sponsored and commercial health programs.
The appointment of Diaz supports this strategy by adding leadership experience across multiple segments of healthcare, including:
- Managed healthcare
- Healthcare services
- Precision medicine
- Healthcare investment
- Corporate governance
- Operational transformation
- Strategic growth
- Public company leadership
This breadth of experience is particularly valuable as healthcare organizations increasingly operate at the intersection of insurance, clinical care, technology, analytics, and value-based payment models.
Board Chair Highlights New Expertise
Frederick H. Eppinger expressed enthusiasm regarding Diaz’s appointment, emphasizing the significant value his experience will bring to the Board.
According to Eppinger, Diaz combines extensive healthcare leadership with deep governance expertise and a proven history of guiding organizations through periods of growth and transformation.
Those capabilities align closely with Centene’s ongoing efforts to strengthen operations, improve member experiences, expand innovation, and deliver sustainable shareholder value.
The Board believes Diaz’s perspectives will help support strategic decision-making as Centene continues advancing its mission and responding to changes across the healthcare ecosystem.
Diaz Shares His Vision
Following his appointment, Paul Diaz expressed appreciation for the opportunity to join Centene’s Board of Directors.
He described the appointment as an honor and praised Centene’s longstanding commitment to improving community health through accessible, high-quality healthcare services.
Diaz indicated that he looks forward to applying his diverse healthcare leadership experience to help support innovation, expand access to quality care, and strengthen the organization’s impact for members, providers, employees, and investors.
His comments highlight a shared commitment to advancing healthcare solutions that improve outcomes while supporting sustainable organizational growth.
Strengthening Governance for Future Growth
Strong corporate governance remains a cornerstone of successful healthcare organizations, particularly those operating at national scale.
For companies like Centene, Board members contribute expertise that helps oversee:
- Strategic planning
- Financial performance
- Enterprise risk management
- Regulatory compliance
- Technology investments
- Quality improvement initiatives
- Executive leadership development
- Long-term shareholder value creation
By continuously refreshing Board composition with experienced healthcare leaders, Centene ensures that its governance structure reflects both current industry realities and future opportunities.
The addition of Diaz introduces complementary expertise while maintaining continuity through a carefully planned leadership transition.
Positioning for an Evolving Healthcare Landscape
Healthcare continues to experience rapid transformation driven by technological innovation, demographic shifts, policy changes, consumer expectations, and new care delivery models.
Organizations must increasingly balance cost management with improved patient outcomes while embracing digital health technologies, data analytics, artificial intelligence, and personalized medicine.
Centene’s Board composition reflects recognition that future success requires leadership capable of understanding both traditional managed care operations and emerging healthcare innovations.
Executives like Diaz, who have led organizations across healthcare delivery, diagnostics, investment, and governance, provide perspectives that can help navigate these complex industry changes.
The Board transition marks an important governance milestone for Centene as it continues pursuing its mission of transforming the health of communities, one person at a time.
Kenneth A. Burdick leaves behind a legacy of thoughtful leadership, operational expertise, and dedicated service that contributed meaningfully to the company’s strategic development. His retirement concludes years of impactful involvement in healthcare leadership while opening the door for a new generation of governance expertise.
Meanwhile, Paul J. Diaz joins the Board with an extensive record of executive success across healthcare services, precision medicine, investment management, and corporate governance. His appointment reflects Centene’s focus on strengthening leadership capabilities that support innovation, sustainable growth, and improved healthcare outcomes.
As the healthcare industry continues evolving, these Board changes position Centene to benefit from experienced leadership while remaining focused on its mission of delivering high-quality, affordable healthcare solutions to millions of members across the United States. With a refreshed Board that combines continuity, expertise, and strategic vision, Centene is well-equipped to advance its long-term objectives and continue making a meaningful impact on the communities it serves.
Source link: https://investors.centene.com/
